NurrOn Pharmaceuticals
Phase 1An innovative pharmaceutical company
Founded
2016
Focus
Small Molecules
About
An innovative pharmaceutical company
Funding History
2Total raised: $48.2M
Grant$3.2MMichael J. Fox FoundationJun 15, 2022
Series A$45MMPM CapitalMay 15, 2021
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile